FAGAX
Price
$215.27
Change
-$0.42 (-0.19%)
Updated
Dec 3 closing price
Net Assets
30.35B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

FAGAX vs VIGRX

Header iconFAGAX vs VIGRX Comparison
Open Charts FAGAX vs VIGRXBanner chart's image
Fidelity Advisor Growth Opps A
Price$215.27
Change-$0.42 (-0.19%)
VolumeN/A
Net Assets30.35B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
FAGAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
FAGAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAGAX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. FAGAX (30.4B). VIGRX pays higher dividends than FAGAX: VIGRX (0.30) vs FAGAX (0.00). FAGAX was incepted earlier than VIGRX: FAGAX (29 years) vs VIGRX (33 years). FAGAX (0.74) is less costly to investors than VIGRX (0.17). FAGAX is a more actively managed with annual turnover of: 56.00 vs. VIGRX (11.00). FAGAX has a lower initial minimum investment than VIGRX: FAGAX (0) vs VIGRX (3000). FAGAX (18.78) and VIGRX (18.49) have marching annual gain over last year. VIGRX return over 5 years is better than : 99.11 vs. FAGAX (49.66).
FAGAXVIGRXFAGAX / VIGRX
Total Expense Ratio0.740.17435%
Annual Report Gross Expense Ratio0.740.17435%
Fund Existence29 years33 years-
Gain YTD20.94519.764106%
Front Load6%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.4B357B9%
Annual Yield % from dividends0.000.30-
Returns for 1 year18.7818.49102%
Returns for 3 years122.96110.82111%
Returns for 5 years49.6699.1150%
Returns for 10 years252.79349.1372%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT